Avantel

Quick check

The five things to look at first. Open one for more.

• DebtAdequate safetyRated A- by 2 agencies.
• ResultsGrowingIn the Jun 2026 quarter, sales rose 36% and profit rose 67% from a year earlier.
• DilutionNo new sharesNo new shares issued in the last year, so existing shareholders' slices were not cut.
• PromotersSteadyThe promoters (founders or parent) own 37% of the company, about the same as in Jun 2025.
• ValuationExpensive vs its pastThe share trades at 211.4 times its yearly earnings (P/E), pricier than 84% of the time in the last 5 years. Its usual P/E is about 27.

Avantel against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

• Valuation (P/E)211.4 against a typical 72.2: pricier than most peers (1st = cheapest).30th of 33
• Sales growth+35.7% against a typical +30.4% from a year earlier.13th of 28
• Profit growth+66.9% against a typical +8.9% from a year earlier.5th of 27
• Share price, 3 months−15.2% against a typical −2%.25th of 32
• Size₹ 3,605.9 Cr. market value against a typical ₹ 4,442.2 Cr. (1st = largest).15th of 28

Exchange filings and their impact on the company.

• 26 Oct 2026Amalgamation/MergerLow impactNeutralPrice −0.3% that day
  Avantel to absorb tiny medical-devices subsidiary with no new shares, leaving business essentially unchanged.

  Avantel's board on October 26, 2026 approved merging its wholly-owned subsidiary Imeds Global Private Limited into Avantel, subject to NCLT and other approvals, with no new shares or cash payment. Imeds had FY26 revenue of Rs 1.6 crore and net worth of Rs 21.8 crore versus Avantel standalone revenue of Rs 221.35 crore and net worth of Rs 356.5 crore. The board also appointed Vice President-Technical Nimmagadda Sreenivasa Rao as Director (Technical) for three years. The merger simplifies the group structure but does not change consolidated scale or shareholding.

  Full analysisFiling
• 26 Oct 2026Outcome of Board MeetingHigh impactVery positivePrice −0.3% that day
  Strong Q2 with 34% sales and 60% profit growth signals ~30% higher revenue and profit next year despite rising debt.

  Avantel reported strong Q2 FY27 results with consolidated revenue of Rs 74.4 crore, up 34% from last year, and net profit of Rs 6.8 crore, up 60%. Half-year sales of Rs 144.8 crore and profit of Rs 12.2 crore are already over 65% of last full year. The board also approved merging its wholly-owned healthcare subsidiary Imeds Global into itself and appointed Nimmagadda Sreenivasa Rao as Director Technical for three years. Debt rose to fund inventory and new plant, but earnings momentum is strong.

  Full analysisFiling
• 10 Oct 2026Bagging/Receiving of orders/contractsLow impactPositivePrice +4.7% on 12 Oct
  Avantel won a Rs 12.04 cr L&T satcom AMC order executable till Oct 2028, adding ~2% to next-12-month revenue.

  Avantel Limited received a purchase order dated October 9, 2026 from Larsen & Toubro Limited for comprehensive annual maintenance of Satcom equipment. The order is worth Rs 12.04 crore inclusive of taxes and is to be executed by October 2028. The small domestic service order adds about two years of recurring maintenance revenue visibility but is only ~5% of annual sales.

  Full analysisFiling

Results dates and other board meetings. Full calendar

Compounded yearly rates over each period.

Listed companies in the same business.

Abburi Vidyasagar

Chairman of the Board, Managing Director

Abburi Sarada

Chief Financial Officer, Whole Time Director

D. Rajasekhara Reddy

Company Secretary, Compliance Officer

Peddi Bala Bhaskar Rao

Additional Executive Director - Operations

Abburi Sidhartha Sagar

Whole Time Director - Strategy & Business Development